The Medical Alley Podcast (Presented by Gamut One Studios)
Gain insights from leaders as they discuss their experiences guiding the organizations that make Medical Alley the epicenter of health innovation and care. Join us for conversations with top healthcare CEOs, startup entrepreneurs, and other experts in healthcare community who are doing innovative work right here in Medical Alley.
The Medical Alley Podcast (Presented by Gamut One Studios)
Smaller Devices, Bigger Challenges with Sean Gallimore, Chief Operating Officer at Microcare
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
As medical devices become smaller and more complex, cleaning and surface treatment become increasingly challenging and more important to get right.
On this episode of the Medical Alley Podcast, Sean Gallimore, Chief Operating Officer at Microcare, explains why manufacturers should consider cleanability early in the design process. He shares how precision cleaning, coatings and lubricants can help address issues with complex geometries, sensitive materials and device performance.
The conversation also explores how collaboration between manufacturers and chemistry experts can solve unique challenges, and how miniaturization, new materials and sustainability are shaping the future of medical device manufacturing.
We’re continuing the conversation at MD&M Midwest! Join Sean Gallimore, Juan De Paz-Lavelle and Matt Lingenfelter of MicroCare Medical for:
“Designing for Cleanability: The Hidden Key to Faster Launches and More Reliable Medical Devices”
📅 October 29 | 12:45–1:30 CT
📍 MedTech Theater (3921) | Minneapolis Convention Center
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
Ben Wagner 0:00
Is the video on your website so old that no one even recognizes your products anymore? Do people stroll past your booth because your visuals scream last decade? And those team portraits-do they say this is us or that was us once upon a time? At Gamut One Studios, we help you say goodbye to good enough and hello to visuals that truly represent you and your brand today. From attention-grabbing product photography to cinematic video and breathtaking drone footage, we craft visuals that tell the unique story of your innovations. Gamut One Studios is your one-stop creative partner, an expert team with deep industry knowledge, trusted by startups and global brands alike, to deliver end-to-end visual solutions. Let's create something remarkable together. Visit gamutonestudios.com to learn about the powerful new visuals that await you. Hi everyone, and welcome to this episode of the Medical Alley Podcast, where we explore the people, the ideas, and the technologies shaping the future of healthcare. I'm your host Ben Wagner. Great to be with you here again this week. Today we are taking on one of the biggest questions facing our healthcare system: How do we pay for it in a way that's sustainable for patients, providers, and the organizations financing care, hospitals and health systems are navigating rising costs, workforce pressures, and a reimbursement model that often does not reflect the true cost of delivering care. And while our health systems have spent years finding ways to operate more efficiently, there's a larger question at hand: Can the financing model itself continue to work as it does today? Joining me to unpack that is James Hairford, the CEO of Fairview and a past chairman of the Medical Alley Board of Directors. James, welcome to the podcast. Thanks for being with us today,
James Hereford 2:02
and thanks for having me.
Ben Wagner 2:04
So, for those of our listeners who may not recognize you from your day job as the president and CEO of Fairview, give me a little bit of a sense of what got you into healthcare. What keeps you motivated to do the work that you are doing every day?
James Hereford 2:17
I'm a bit of a random walk from a career perspective. I was working on my PhD in statistics at the University of Washington. We started having kids. I got revenue motivated, and ended up doing some work at Boeing as they were building out their quality program in the very early '90s. Out of that came the opportunity to do consulting, so their suppliers could meet the new requirements. And just randomly, one of my clients ended up being Group Health Cooperative in Seattle, integrative financing and care delivery organization. But frankly, I didn't know anything about healthcare. But their money spent the same as everybody else I was talking to, as they were trying to implement total quality. And I started doing some consulting for them and fell in love with healthcare. I mean, more smart people per square unit space than anywhere, mission orientation. You know, there for very specific and very appealing reasons. And then, frankly, processes were so broken I couldn't help but contribute some value. I thought, well, I'll do this for a little bit as a consultant, and I'll get back to getting my dissertation completed and move on. And 20 years later, I was still there running their care delivery system at that point, and then got recruited down to California.
Ben Wagner 3:25
Interesting, and then from California to the Twin Cities. How many years ago?
James Hereford 3:30
10 years ago.
Ben Wagner 3:31
Okay.
James Hereford 3:32
Yeah, been a really fun slash interesting time here at Fairview and being in the Twin Cities.
Ben Wagner 3:40
Well, you mentioned the processes being broken, and that's something that you've been working on trying to make healthcare more efficient. For somebody who is outside of healthcare delivery, how do you explain, sort of in layman's terms, the basic economics of running a hospital today? Where does the money come from? Where are the biggest disconnects that you see between what it costs to provide care and what hospitals are actually paid.
James Hereford 4:05
Well, let's start with the nature of a hospital, right? So, a hospital is a a very capital-intensive environment, right? Big, expensive buildings, big, expensive equipment, very specialized kind of uses for those buildings and that equipment, very expensive people who run those can use that equipment in those very expensive buildings. So it's very capital intensive. The standard working is assumption is that you need about a 3% margin or profit, which is really just a reinvestment as a not for profit. We obviously we don't pay dividends or there's no shareholders other than the community themselves, and so that 3% is simply a reinvestment into the hospital. All right. So now to your question: How do you get paid? There are two major sources: the government, Medicare and Medicaid, and there are commercial entities, businesses. Medicare is a. About 80 cents on the cost dollar. So you take what it costs me to deliver whatever the procedure or the the care is. I get paid about 80% of that from a Medicaid perspective. So getting paid less than what it costs you to produce that is not a great business model. Medicaid's even worse. Medicaid's around 73 cents on the dollar, and these are national figures, but they apply to Minnesota as well. What happens then is commercial entities have to pay much, much more, and we cross subsidize. So we take that money and we move that over to balance the books to pay for the care that we're not getting reimbursed at the full cost of care. So essentially, it's a hidden tax on business, right? Because businesses are getting taxed to make up for governmental shortfalls, and the problem is in the last four years. I think every year has been a significant double-digit increase, more than 10 to 15% Some cases much more for commercial entities, because the fundamental problem for us and many healthcare organizations is if I look at our core business, if I blend those revenue increases of governmental and commercial, it's about 2% more per year. We're a $9 billion organization, so that 2% is matched up against the cost increases, and we're largely just labor and supplies that makes up our cost structure, labor goes up about 4% at least every year, and supplies, depending on what's going on in the broader economy and the broader supply chains, goes up four or much more percent. And so let's just assume costs go up on an average about 4% per year, and my revenues are going up about 2% Well, that 2% delta is $180 million on a 9 million $9 billion organization. I have to make that up every year just to stay even. That is not a business model that can sustain itself. And in addition to that, even make it more challenging. In the early 2000s, consumer defined health plans and the idea of copays and coinsurance and deductibles was introduced, and the theory was, you know, legitimized by saying, "Look, people can't have their head in the game unless they have skin in the game. Patients have to have some economic consequences, and so deductibles were introduced, usually around 100, $200. Well, today those deductibles are 5000, even $10,000, and what's basically happened is the way that commercial entities have continued to be able to afford to provide those benefits is they've moved more and more of those costs to the individual. But from a hospital perspective, now I not only have to get paid by the the plans or whoever the payer is, but I also have to go then chase the debt. And typically, Minnesota certainly is this way. It's very difficult, and it's not a great PR thing to be overly aggressive in chasing that debt. So that premium dollar basically got shifted to individuals, and then the obligation for chasing that fell to hospitals. It's a wacky business model, and we have to take a look at this because we cannot expect commercial entities to continue to make up that difference. And I think they likely won't. They'll look for alternatives. And you know, there's legislation that was introduced in 2016 that allows them to pursue you know instead of a defined benefit plan, a defined contribution plan, like most of the investment retirement accounts we have.
Ben Wagner 8:26
You brought up an interesting point there. It's not just that we have people who are uninsured; it's we have people who are insured but also can't afford the cost of care.
James Hereford 8:36
That's right. It's it's one of the things that's really changed a lot in the last five to six years, is the letters I get from patients are usually about economics, but they're from people who historically would have said have great insurance. Right, they're employed, getting insurance from their employer. You know, there used to be that was like first dollar coverage. You didn't even think about paying for anything in healthcare. And as I said, that changed in the early 2000s. But now, in the U.S. average person can't handle a surprise $500 bill. Well, when you're talking about healthcare, the bills are much bigger than that, and certainly the the copays and the coinsurance and deductibles are much larger than that. And so the letters I get are from people who have good insurance, can't afford their bills, can't afford the care, and we know the data is very complete. People are delaying care, necessary care, because they feel like they can't afford it. Well, that's not a great system if that's the case as well.
Ben Wagner 9:38
What's the long-term effect? I mean, that leads to more expensive chronic care down the line. That's exactly right.
James Hereford 9:43
I mean, it's not like the care goes away, the care need goes away. It gets delayed, and disease progresses and it gets worse. The same thing's going to happen on the uninsured side with the Medicaid cuts. Is it's not like the care needs go away, but they present in different ways and in a more acute way. They end up in REDs. Where Mtala would say we have to care for them, and appropriately so, we should care for them. But whatever the condition is, going to be more acute, more difficult, more expensive, and a bigger hassle for the patient. That's what happens if you don't have insurance.
Speaker 1 10:15
Clearly, the model is not sustainable.
James Hereford 10:17
Clearly,
Ben Wagner 10:17
and you've mentioned a number of you know the the cost pressures that hospitals are facing: rising labor costs, supply costs going up, uncompensated care. As you look at kind of all of that in totality, from your perspective, what do you see as kind of the the the biggest concern for you over the next, let's say, five to 10 years?
James Hereford 10:38
Well, I think the sustainability of the system and ICRA legislation that was passed in 2016, which provides for a avenue if commercial entities want to get out of the defined benefit game and move to a defined contribution game, which is essentially saying, here, here's your money, you pay for your health care, go to the exchange, go to whatever access points you have to buy insurance, you buy it. There may be some supplemental dollars in there, but basically, you now are on the hook with some money from your employer to go buy your insurance. The hard part for hospitals is the reimbursement levels for us in a independent, like the small market, small market, small group market and independent market, individual market is much lower than the commercial market. So right away we're taking a pretty significant haircut. It's still slightly above Medicare rates, which tends to be the index we use to say you know to be able to make relative comparisons. Slightly above, but not a lot. And so it'll put already distressed hospitals into an even more significant level of distress to the point of not being viable. I think there's a very real chance if we don't do something soon, that's exactly what we're going to see over the next five years.
Ben Wagner 11:54
What do you say to people who say, "Well, hospitals just need to become more efficient. They need to become more modernized. Find ways to cut costs. What do you say to to that kind of criticism,
James Hereford 12:02
you know, there's a certain level of truth to that. But I will say, you know, if you look at any business, it's a product of so what are the cost of goods sold, right? What are the input costs, and what's the price point that I can set for that good? And that delta is my margin, assuming it's positive. Could be negative, but hopefully positive. Well, think about the input costs: labor and supplies. Supplies are largely made up of medical technologies, information technologies, the certain kind of middlemen costs of distribution and getting supplies to us. That's about 30 to 40% of the overall spend. I have no control over those supply costs, essentially, I am a price taker. I can't not big enough to negotiate in any serious way. And GPOs were really built to create that negotiating power, but that has largely kind of played out, and we don't get as much lift as we used to on the labor side. I have to compete in the labor market that everybody else does, so I have to pay what the market pays. So again, I don't have a lot of control over my input costs. If I look at the output, the price, I have no ability. I have to negotiate my price. I don't negotiate with the government. So Medicare and Medicaid is what they give me, and I negotiate with payers for the commercial reimbursement. But again, it's a negotiation, and then that negotiation is only the beginning of trying to get paid because then you got to fight your way through all of the prior authorizations and all the games that get played between care delivery systems and help plans to actually get reimbursed. And so the only thing you have left, if you can't control your input costs and you have very little control over your prices is how efficient are you in using those large capital assets? So you know, in in the Twin Cities where our commercial reimbursement is relatively low, if you compare it across the country, we've spent the last six to seven years focused just on that. Can we improve not only efficiency because that tends to be about economics, but the effectiveness of our processes, which includes how much do we spend to do a process, but also you know what are the outputs here? Well, one is how much it costs, but what's the level of quality? What's the level of service? What's the level of engagement? Because we're still largely our values transmitted through people, so you have to be able to really. The only thing I can focus on is how do we run our hospital, and in the case of a Fairview, an integrated system, increasingly efficiently, but still produce all of the dimensions of outcomes that I need to produce. Because people assume they're in a safe, high-quality place. That's the assumption in any healthcare interchange, you don't get rewarded for having higher quality, but you get penalized if you have bad quality or bad safety. What they judge us on is customer service. So I can't simply say we're going to do the most parsimonious, lean process that doesn't create a good experience, and I think. Creating an experience in healthcare is hard as any any environment there is because people aren't coming to us like on a cruise like they're not coming for a good time they're coming at a point where they have incredibly significant needs typically to the point of even doubting their own mortality and our job is to create a supportive experience for them and to be able to knit all the pieces of a healthcare experience together, because it usually isn't in a single site; it usually spans multiple sites. And you know what I always say is we're really good at the spots; we're not so good in the in the space between them. And we've focused a lot on how do we really own that complexity and create better experiences. And you know, our data certainly reflects improvement, but we've got a ways to go. Right, where our goal is to be our net promoter score in the '90s, which that's hard. But I think that's the thing that people most understand about what's happening in healthcare is the experience they get out of it, and too often it's frustrating.
Ben Wagner 15:56
Is that one of the big takeaways? You know, you've you've had some stories recently about Fairview's success over the last couple of years-is that one of the bigger takeaways for you? Is creating an inviting and welcoming climate for patients, or what do you what do you what do you attribute to kind of that success that you've seen at Fairview over the last 345, years?
James Hereford 16:17
Well, I think a lot of it is our investment in process improvement, and both in terms of the direct investment to just getting better at what we do, but also our management system is really modeled with the idea of being able to support continuous improvement at scale. Anybody can go in and improve a process. The problem is you go back in two weeks, and the process doesn't look like that anymore. It's kind of regressed to its original form. So how do you maintain that, and then how do you build on that? And so we use a operating system, a management system modeled off of the things that Toyota and other lean organizations have done in terms of using using visual systems and having a you know a cascade of strategic A three, so everybody can line up and say, "Okay, how am I contributing to the success? Not just in my my unit or my clinic, but how does that then add up to success for the organization? And a lot of what's happened over the last three to five years, and thanks for referencing that, we've had about a $600 million turnaround in three years, a lot of that was based off of just hard work by our operators and all those who support our operators to improve processes. Yeah, because that has been a big story, I think, here in the Twin Cities in terms of the success of of the health system and of Fairview. And so, I'm curious too. You have been a leader in ringing the bell on this system that we have is unsustainable. The natural next question is, what would be an alternative? What are some maybe incremental changes or ways that we can shift this model to make it more sustainable for health systems like yours to continue to be successful? Yeah, it's a great question, and I wish I had the the answer right, and often what we do is we look at the OECD countries and say, "Well, gee, they're getting better outcomes. They must be doing it right. The problem is when you peel that back, it's actually yes, they do get better outcomes in many ways, not in all dimensions, but in many ways. And the U.S. spends much much more than any other OECD country for healthcare. If you normalize that for the social spend and the medical spend, U.S. is right in the middle of the pack of OECD countries. Well, what that tells me is those countries have invested more into the precursors of disease, right? So social determinants of health. Do you have a stable place to live? Do you have access to decent food? Can you get an education? Can you pursue a gainful career? And if you have those things, guess what? You're more healthy. Independent of what I can do and what our amazing clinicians can do within the walls of our hospitals and clinics, and if you look at the models of OECD countries, they're all over the place. There's, you know, the NHS model, kind of single payer, monolithic single care delivery system. But even that's not pure, right? Because you can buy private insurance in in England. You have formalized two tier models: Australia, Switzerland, the Netherlands are more like that. You have the Bismarck model, the ones where it's just premium support. So Germany does that. All of those countries are all over the place in their models, and all vary a little bit in terms of their outcomes. But all are fairly close in terms of their medical outcomes, and fairly close in terms of the investments they make on the social side, the challenge in the U.S. is we've invested a lot more on the medical side, but not all that much on the social side, and we're cutting that back a bit. That makes it more difficult not just for people to have a high quality of life, but also a high quality of health. The other thing with OECD countries. Is they enjoy in large part the lower input costs because they can negotiate as a country for their drugs, their med tech, etc. I can't do that. I can't get that benefit. So in many ways, the U.S.
James Hereford 20:12
is paying for the R and D and the you know amazing innovation that happens here that then gets sold overseas in OECD countries and others at a much reduced price than what I can access it for, so it's hard to make those comparisons. I I think that those models though are fairly standard. What the hardest part of healthcare reform is how do you engage in a meaningful conversation, and who do you engage with in that conversation? Because there are a lot of people doing quite well in this current system and have no desire to see it change. And so politically, how do you even have this conversation? But my frustration has largely been it's a little bit like with my peers, we're not having the conversation necessarily about what we want healthcare financing to look like. We're basically spending our time trying to defend the status quo, which the status quo can't persist. It will just not go on. It's going to change, and we need to, especially as care delivery systems, start to take much more of a leadership role about what needs to happen and how, because it's the care delivery systems that can actually. That's where the value is created, right? That's where patients are seen. That's you know, doctors, nurses are some of the most trusted professions in the U.S. It's not health plans, right? It's not PBMs. It's not distributors. Those are not the places where you can alter the course of health in a more effective way. But we so we have to, I think, as care delivery systems step up and start talking about what we want differently, because we're the ones who I think are at the end of the day have to be depended on to create that value.
Ben Wagner 21:49
Is Minnesota having or speaking loudly enough to be a leader in this conversation? We think of Minnesota, and it is sort of that proving ground for innovation. This seems like one of the biggest questions we could tackle. Are we talking about this enough?
James Hereford 22:03
No, we're not talking about this enough. I'm not sure we're talking about it in a in a meaningful way at all. And it's one of the things that I think has really changed in Minnesota. I remember coming here in the 1990s, and if you wanted to talk about healthcare and healthcare delivery and healthcare policy, Minnesota was the place to be. I mean, it was advancing HMOs. It was advancing purchaser coalitions. There were a number of things that happened uniquely in Minnesota. We're really kind of the first movers. We haven't been in that position for you know 20 plus years. Now there's still a ton of innovation going on. It's more innovation in the med tech side, in some of the iTech, and the startups and the new offerings. I think the challenge, though, for larger care delivery systems is that none of those by themselves are enough. There's not enough innovation there, even with AI. There's not enough innovation there to work effectively in the current economic structure.
Ben Wagner 23:05
Do you think AI will have a significant enough impact to make a difference in this conversation?
James Hereford 23:12
Could be. I don't know. I feel like we're in the late '90s when we were all talking about the internet and you know the World Wide Web and it's going to change everything. The problem is we didn't know how. pet.com. didn't last long. Yeah. There were drugstore.com. didn't last long. I think we're in the similar stage with AI. We know it's going to change things significantly, even more so than the World Wide Web itself. We just don't know how exactly. But you think about like when we say AI, we're usually referencing the the foundational large language models, right? The ChatGPTs, the Clods, etc. You think about the rate of advancement and what those represent. So you know these were introduced three years ago, brand new concept, and you look at how amazing they are in many ways now. They still have their problems and deficiencies, but the advancement is undeniable. And what what do they do? Well, they take and manage knowledge incredibly effectively and create a two-way interface between the user and the AI to really be able to make it much more accessible to be able to access that knowledge. Well, what's healthcare? Healthcare, in large part, is knowledge management, and so the ability to use AI to more effectively manage knowledge in healthcare, both for the betterment of our clinicians but also for our patients, is going to be significant. One of my favorite stats is, if you were a brilliant medical student in 1950 and learned the entire body of clinical knowledge. At the rate of it was expanding in 1950, you wouldn't expect it double in two until the year 2000. Okay, fast forward, year 2020, you're a brilliant medical student and you've mastered the entire body of clinical knowledge. Now it doubles in seven months, so it's a bit of a pretense to say, yeah, a human being can keep pace with the knowledge expansion that's happening in healthcare, and we really are just at the edge of you know potential with the synthetic biologies and what's going to happen-a kind of Cambrian-like explosion of knowledge, so there's no way we can have we can't specialize enough to do that, right? That's what we've done. We specialize, subspecialize, sub subspecialize to make the domain of knowledge smaller so people can master it. That fundamental dynamic is going to shift, and the implications of that for our care models and who does the work and how many people we need to do the work is going to be considerable, but nobody knows exactly how that's going to work and how that's going to evolve. And so, it's important for us to stay. We don't want to be on the bleeding edge. We want to be proximate to the leading edge and being able to really help think about and think for ourselves how can we best leverage this amazing technology. At the end of the day, though, I still believe healthcare is a hands-on kind of human-to-human experience. So I don't see outside of some fairly trivial applications AI replacing clinicians or replacing the need for care delivery. But it probably replaces the need for a lot of Google searches that aren't all that effective today about healthcare for both certainly patients and lay people, but then you know how do physicians stay current and how do they access that information? And we have various tools that we use for that, but AI certainly made them more powerful.
Ben Wagner 26:37
And there's a tremendous level of of trust in these sort of an inherent trust in these LLMs. When you put something in, what it comes when it comes back to you, I don't know how to even describe it, but I think we trust the data that's coming back to us. Now, there's obviously some questions about how trustworthy is the data, right? The garbage in, garbage out philosophy. But I think that's just a really interesting component of the way that AI has exponentially grown, like you said over the last three years. You mentioned Minnesota needing to take a leadership role in this conversation. What are some of the steps that need to be taken, and where do maybe the conversations around policy that we need to be having? Because you brought up an interesting point earlier about you know this is not an issue that many people are looking to address, and that includes politicians. Likely because the solution is going to take longer than an election cycle. So, how do you get the conversation going?
James Hereford 27:31
Right, and there's a fairly high probability that you know there's going to be a certain percentage of people who don't like it. Yep, many of whom fund a lot of political agents at the federal and state level, and that you're going to get penalized for any support to a different way. So there's not a political calculus. That's what makes it so hard. But I also think that's why a state by state approach can work. It will require some cooperation from the federal government, but not necessarily significant legislation. It's more, you know, waivers from CMS, etc. to be able to support a state by state approach. And my premise is Minnesota is perfectly positioned. We have urban, we have rural, we have suburban environments. We're a state of 6 million, so it's tractable, but it's meaningful. It's not tiny, but it's not so huge. You can't do California because California is not even a single state. I mean, it feels like three different states. And Minnesota has a history of being a leader in thinking about how to provision healthcare for the citizens of Minnesota. And you know, if if there's any environment in which this can take place, it should take place in Minnesota, and that's one of the things I'm going to be working on over the next couple of years: is how to really get that conversation going, not just in Minnesota, but I think at a national level. But to try to position Minnesota in a place where we can be a thought leader and maybe an early pioneer in looking at a different way to finance and deliver healthcare.
Ben Wagner 29:02
I've asked you a lot of really serious questions and to think real deeply about some big, you know, big topics here too. But James, you know, as we kind of close this conversation, I'm curious, you know, what what's your favorite part about about your job? What is what's what's the best part about your role leading Fairview?
James Hereford 29:17
A long time ago, I was at a cocktail party, and I ran into one of our ED docs and I asked her, "So how's your job going? She goes, "Look, I have an 8020 job. What's an 8020 job? She goes, "80% of the time, you don't have to pay me. 20% of the time there's not enough money in the world. I think mine's closer to 8515 or 9010. I think I have a. It's an amazing opportunity to be the CEO of a of a healthcare organization, what I enjoy most, I think, is seeing the results of people feeling like they have the ability to make positive changes in their environment, and that's true at the you know my senior leader level. It's true at a frontline manager level, and it's true at a frontline level where people. Feel like they have a sense of some control, and say, you know what, we can make this better. We can address this issue. We can improve this process, and then to hear them brag about it, which is the best part of my job, is you know go to a clinic, go to the floor of a of a hospital, and hear the people who do the work talk about the problem and how they addressed the problem and the results they got and the inherent pride of them as a team coming together to make those changes. There's nothing better than that. There's a lot of great things about my job, but that's the thing I think I enjoy the most.
Ben Wagner 30:38
Well, James, I really appreciate this conversation. Thank you for your insight. More to come, certainly. Probably one of many conversations we could have on this topic. But thank you for your time today,
James Hereford 30:47
Ben. Thank you for taking time to talk to me.
Ben Wagner 30:50
That is James Hereford, the CEO of Fairview, and I'm Ben Wagner. That is another episode of the Medical Alley podcast. Thank you for tuning in.